This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spangler, S. K.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spangler, S. K.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 1998, p. 1253-1255, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin against 20 Pneumococci

Sheila K. Spangler,1 Gengrong Lin,1 Michael R. Jacobs,2 and Peter C. Appelbaum1,*

Departments of Pathology (Clinical Microbiology), Hershey Medical Center, Hershey, Pennsylvania 17033,1 and Case Western Reserve University, Cleveland, Ohio 441062

Received 28 August 1997/Returned for modification 31 January 1998/Accepted 20 February 1998

The postantibiotic effect (PAE) (10 times the MIC of quinolones, 5 times the MIC of macrolides) and postantibiotic sub-MIC effect (PAE-SME) at 0.125, 0.25, and 0.5 times the MIC were determined for levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. Quinolone PAEs ranged between 0.5 and 6.5 h, and macrolide PAEs ranged between 1 and 6 h. Measurable PAE-SMEs (in hours) at the three concentrations were 1 to 5, 1 to 8, and 1 to 8, respectively, for quinolones and 1 to 8, 1 to 8, and 1 to 6, respectively, for macrolides.


* Corresponding author. Mailing address: Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail: pappelbaum{at}psghs.edu.


Antimicrobial Agents and Chemotherapy, May 1998, p. 1253-1255, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Athamna, A., Athamna, M., Medlej, B., Bast, D. J., Rubinstein, E. (2004). In vitro post-antibiotic effect of fluoroquinolones, macrolides, {beta}-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis. J Antimicrob Chemother 53: 609-615 [Abstract] [Full Text]  
  • Gander, S., Finch, R. (2000). The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of Gram-positive bacteria. J Antimicrob Chemother 46: 61-67 [Abstract] [Full Text]  
  • Davies, T. A., Ednie, L. M., Hoellman, D. M., Pankuch, G. A., Jacobs, M. R., Appelbaum, P. C. (2000). Antipneumococcal Activity of ABT-773 Compared to Those of 10 Other Agents. Antimicrob. Agents Chemother. 44: 1894-1899 [Abstract] [Full Text]  
  • Davies, T. A., Kelly, L. M., Hoellman, D. B., Ednie, L. M., Clark, C. L., Bajaksouzian, S., Jacobs, M. R., Appelbaum, P. C. (2000). Activities and Postantibiotic Effects of Gemifloxacin Compared to Those of 11 Other Agents against Haemophilus influenzae and Moraxella catarrhalis. Antimicrob. Agents Chemother. 44: 633-639 [Abstract] [Full Text]  
  • Davies, T. A., Kelly, L. M., Pankuch, G. A., Credito, K. L., Jacobs, M. R., Appelbaum, P. C. (2000). Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other Agents. Antimicrob. Agents Chemother. 44: 304-310 [Abstract] [Full Text]  
  • Spangler, S. K., Bajaksouzian, S., Jacobs, M. R., Appelbaum, P. C. (2000). Postantibiotic Effects of Grepafloxacin Compared to Those of Five Other Agents against 12 Gram-Positive and -Negative Bacteria. Antimicrob. Agents Chemother. 44: 186-189 [Abstract] [Full Text]  
  • Pendland, S. L., Diaz-Linares, M., Garey, K. W., Woodward, J. G., Ryu, S., Danziger, L. H. (1999). Bactericidal Activity and Postantibiotic Effect of Levofloxacin against Anaerobes. Antimicrob. Agents Chemother. 43: 2547-2549 [Abstract] [Full Text]  
  • Amsden, G. W., Graci, D. M., Cabelus, L. J., Hejmanowski, L. G. (1999). A Randomized, Crossover Design Study of the Pharmacology of Extended-Spectrum Fluoroquinolones for Pneumococcal Infections. Chest 116: 115-119 [Abstract] [Full Text]  
  • Champney, W. S., Tober, C. L. (1999). Molecular Investigation of the Postantibiotic Effects of Clarithromycin and Erythromycin on Staphylococcus aureus Cells. Antimicrob. Agents Chemother. 43: 1324-1328 [Abstract] [Full Text]